ISMRC 2025 (International Symposium on Minimal Cancer)

This international meeting is a fantastic opportunity to gather for three days and share many updated aspects concerning the use of liquid biopsies in cancer patients. Moreover, this meeting covers many new developments of liquid biopsy for clinical implementation, with some specific focuses on the role of liquid biopsy in treatment decision making both for immuno-oncology and targeted therapies. Moreover, special sessions will be dedicated to the new aspects of minimal residual disease detection, early detection and screening cancers, and monitoring disease by blood sampling for tracking resistance mechanisms to different therapeutic.
7 May 2025
to 9 May 2025
IHU RespirERA
, Nice

About the event

Reveal the power of the 6-base genome. Introducing duet multiomics solution evoC. Distinguish 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) together with all four canonical bases to measure multiple modes of biology from a single low-input DNA sample in a single experiment. Identify novel multimodal biomarkers to gain transformative insights into current and future states of disease.

Find the venue

One sample. One workflow. One solution.

Here are the relevant biomodal resources for information. Find poster presentation information, case studies, interviews, and more.

Related resources

Attending from biomodal

Aziz Mustafa

Aziz Mustafa, PhD

Director of Sales and Business Development, Europe

Register now

ISMRC 2025

Stay up to date

Explore recent biomodal news and the events that we’ll be attending in the near future.

Cambridge Epigenetix is now biomodal